Skip to content

Clinical trials

Terminated Phase 2 Attention Deficit Disorder with Hyperactivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Phase 2 Status: Terminated Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20142
20181
20191
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott1
Brlev Agricultural Crops Ltd1
Duke University1
National Institute on Alcohol Abuse and Alcoholism (NIAAA)1
Neurocentria, Inc.1
New York State Psychiatric Institute1
Supernus Pharmaceuticals, Inc.1
The University of Texas Health Science Center, Houston1
Uniformed Services University of the Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity9
Spasm2
Autism Spectrum Disorder1
Brain Injuries, Traumatic1
Cocaine-Related Disorders1
Memory Disorders1
Substance-Related Disorders1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.